Speak directly to the analyst to clarify any post sales queries you may have.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by strong pipeline of vendors, rising prevalence of multiple sclerosis, and disease-modifying therapies.
The multiple sclerosis market in us is segmented as below:
By Route Of Administration
- Parenteral
- Oral
By Type
- Biologics
- Small molecules
By Geographical Landscape
- North America
The report on the multiple sclerosis market in us covers the following areas:
- Multiple Sclerosis Market in US sizing
- Multiple Sclerosis Market in US forecast
- Multiple Sclerosis Market in US industry analysis
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
The report presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.
Table of Contents
Executive Summary
The following companies are recognized as the key players in the multiple sclerosis market in us: AB Science SA, Astellas Pharma Inc., Bayer AG, Biogen Inc., Bristol Myers Squibb Co., F. Hoffmann La Roche Ltd., GeNeuro SA, Glenmark Pharmaceuticals Ltd., Inno BioScience LLC, Johnson and Johnson Inc., Mapi Pharma Ltd., MediciNova Inc., Merck KGaA, Novartis AG, Opexa Therapeutics Inc., Pfizer Inc., Sanofi SA, Sobel Network Shipping Co. Inc., Teva Pharmaceutical Industries Ltd., and Viatris Inc..Commenting on the report, an analyst from the research team said: "The latest trend gaining momentum in the market is rising strategic alliances and partnerships among vendors."
According to the report, one of the major drivers for this market is the strong pipeline of vendors.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- AB Science SA
- Astellas Pharma Inc.
- Bayer AG
- Biogen Inc.
- Bristol Myers Squibb Co.
- F. Hoffmann La Roche Ltd.
- GeNeuro SA
- Glenmark Pharmaceuticals Ltd.
- Inno BioScience LLC
- Johnson and Johnson Inc.
- Mapi Pharma Ltd.
- MediciNova Inc.
- Merck KGaA
- Novartis AG
- Opexa Therapeutics Inc.
- Pfizer Inc.
- Sanofi SA
- Sobel Network Shipping Co. Inc.
- Teva Pharmaceutical Industries Ltd.
- Viatris Inc.